Simon Lovestone, PhD, MRCPsych

Affiliations: 
Old Age Psychiatry King's College London, London, UK 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=134
Website:
http://www.iop.kcl.ac.uk/staff/profile/default.aspx?go=10554
Google:
"Simon Lovestone"
Bio:

http://f1000.com/thefaculty/member/1706461756745652

Mean distance: 23.55 (cluster 51)
 
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Delvenne A, Gobom J, Tijms B, et al. (2022) Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Wesenhagen KEJ, Gobom J, Bos I, et al. (2022) Effects of age, amyloid, sex, and ε4 on the CSF proteome in normal cognition. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12286
Visser PJ, Reus LM, Gobom J, et al. (2022) Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease. Molecular Neurodegeneration. 17: 37
Hillary RF, Gadd DA, McCartney DL, et al. (2022) Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12280
Homann J, Osburg T, Ohlei O, et al. (2022) Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset. Frontiers in Aging Neuroscience. 14: 840651
Visser PJ, Reus LM, Gobom J, et al. (2022) Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease. Molecular Neurodegeneration. 17: 27
Neumann A, Küçükali F, Bos I, et al. (2022) Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation. Molecular Psychiatry
Xu J, Green R, Kim M, et al. (2021) Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort. Biomedicines. 9
Park JY, Lee D, Lee JJ, et al. (2021) A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages. Translational Psychiatry. 11: 590
Kern DM, Lovestone S, Cepeda MS. (2021) Treatment with TNF-α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 7: e12163
See more...